pág. 947
muchos casos, mientras que la paciente puede sobrevivir, el feto no. Dadas estas estadísticas mórbidas,
todos los trabajadores de la salud deben educar al paciente y la familia sobre el trastorno y sus resultados
(17-18).
REFERENCIAS BIBLIOGRAFICAS
1. Stergiopoulos K, Lima FV. Peripartum cardiomyopathy-diagnosis, management, and long term
implications. Trends Cardiovasc Med. 2019 Apr;29(3):164-173.
2. Azibani F, Sliwa K. Peripartum Cardiomyopathy: an Update. Curr Heart Fail Rep. 2018
Oct;15(5):297-306.
3. Wang WW, Wang Y. Peripartum women with dyspnea in the emergency department: Is it
peripartum cardiomyopathy? Medicine (Baltimore). 2018 Aug;97(31):e11516.
4. Gammill HS, Chettier R, Brewer A, Roberts JM, Shree R, Tsigas E, Ward K. Cardiomyopathy and
Preeclampsia. Circulation. 2018 Nov 20;138(21):2359-2366.
5. Koenig T, Hilfiker-Kleiner D, Bauersachs J. Peripartum cardiomyopathy. Herz. 2018
Aug;43(5):431-437.
6. Metra M. June 2018 at a glance: peripartum cardiomyopathy and pathophysiology, prognosis, and
device therapy of heart failure. Eur J Heart Fail. 2018 Jun;20(6):949-950.
7. Cruz MO, Briller J, Hibbard JU. New Insights in Peripartum Cardiomyopathy. Obstet Gynecol Clin
North Am. 2018 Jun;45(2):281-298.
8. Damp JA, Arany Z, Fett JD, Blauwet L, Elkayam U. Imbalanced Angiogenesis in Peripartum
Cardiomyopathy (MCPP). Circ J. 2018 Sep 25;82(10):2689.
9. Bauersachs J, Koenig T. Devil in Disguise: Hints and Pitfalls in Diagnosis of Peripartum
Cardiomyopathy. Circ Heart Fail. 2018 Apr;11(4):e004620.
10. Haghikia A, Schwab J, Vogel-Claussen J, Berliner D, Pfeffer T, König T, Zwadlo C, Moulig VA,
Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R, Stangl V, Kühl U,
Podewski E, Kindermann I, Böhm M, Sliwa K, Hilfiker-Kleiner D, Bauersachs J. Bromocriptine
treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction. Clin Res
Cardiol. 2019 Mar;108(3):290-297.